BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raju GSR, Pavitra E, Varaprasad GL, Bandaru SS, Nagaraju GP, Farran B, Huh YS, Han YK. Nanoparticles mediated tumor microenvironment modulation: current advances and applications. J Nanobiotechnology 2022;20:274. [PMID: 35701781 DOI: 10.1186/s12951-022-01476-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kang Y, Li S. Nanomaterials: Breaking through the bottleneck of tumor immunotherapy. Int J Biol Macromol 2023;230:123159. [PMID: 36610572 DOI: 10.1016/j.ijbiomac.2023.123159] [Reference Citation Analysis]
2 Abballe L, Spinello Z, Antonacci C, Coppola L, Miele E, Catanzaro G, Miele E. Nanoparticles for Drug and Gene Delivery in Pediatric Brain Tumors' Cancer Stem Cells: Current Knowledge and Future Perspectives. Pharmaceutics 2023;15. [PMID: 36839827 DOI: 10.3390/pharmaceutics15020505] [Reference Citation Analysis]
3 Ke W, Crist RM, Clogston JD, Stern ST, Dobrovolskaia MA, Grodzinski P, Jensen MA. Trends and patterns in cancer nanotechnology research: A survey of NCI's caNanoLab and nanotechnology characterization laboratory. Adv Drug Deliv Rev 2022;191:114591. [PMID: 36332724 DOI: 10.1016/j.addr.2022.114591] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wu P, Han J, Gong Y, Liu C, Yu H, Xie N. Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications. Pharmaceutics 2022;14:1990. [DOI: 10.3390/pharmaceutics14101990] [Reference Citation Analysis]
5 Sredojević D, Lazić V, Pirković A, Periša J, Murafa N, Spremo-potparević B, Živković L, Topalović D, Zarubica A, Jovanović Krivokuća M, Nedeljković JM. Toxicity of Silver Nanoparticles Supported by Surface-Modified Zirconium Dioxide with Dihydroquercetin. Nanomaterials 2022;12:3195. [DOI: 10.3390/nano12183195] [Reference Citation Analysis]